Platform that utilizes Artificial Intelligence and chatbots to manage chronic illness at massive scale

Globally providing immediate healthcare access for a happier, healthier, longer life

A groundbreaking liquid biopsy test to screen for early-stage cancer and disease


Rewriting DNA synthesis to endless possibilities

Transforming the healthcare industry through clinical and economic insights,
adherence and healthcare outcomes

AMV is the leading early-stage venture capital firm investing in digital health

AMV Updates

Five digital health trends investors are watching in 2017

Skip Fleshman
Feb 16, 2017

The healthcare market is enormous with over $3.2 trillion of annual spend in the United States in 2015, and the sector has had significant regulatory changes over the past seven years largely driven by the Affordable Care and HITECH Acts.

The Road Not Traveled: Journey of a PhD into the Biotech Business and Finance Industry

Luke Lee
Timmerman Report
Feb 16, 2017

There are lots of things people can do with scientific training, and the number of options can seem bewildering at times. And many are seeking some kind of repeatable path to transition into a competitive job market.

Why did HealthSpot fail? The telemedicine industry weighs in

Skip Fleshman
MedCity News
Jan 7, 2016

“That was a lot of money to raise for this stage of a company,” said Skip Fleshman, a partner with digital health investment firm Asset Management.


AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.

2595 E Bayshore Rd, Suite 240
Palo Alto, CA

© 2019 Asset Management Ventures
All Rights Reserved